Myriad Genetics (MYGN) Q2 2026 Earnings

May 5Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.09
-0.04
0
0.05

Details

Expected EPS
-0.068027
Actual EPS
-0.09
Surprise EPS
-0.02
Surprise Percent
-32.3%

Description

⁨Myriad Genetics⁩ (⁦MYGN⁩) has reported earnings of ⁦-0.09⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts